| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,827 |
2,611 |
$199K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,107 |
1,024 |
$80K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
929 |
902 |
$69K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
176 |
170 |
$14K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
481 |
460 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,966 |
949 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,185 |
1,157 |
$5K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
954 |
916 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
362 |
326 |
$784.80 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
95 |
92 |
$564.27 |
| 87807 |
|
57 |
54 |
$254.65 |
| 99001 |
|
493 |
475 |
$48.82 |
| 94760 |
|
2,041 |
1,946 |
$28.62 |
| 81002 |
|
30 |
28 |
$28.15 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
14 |
13 |
$5.77 |
| 99051 |
|
1,348 |
1,286 |
$5.00 |
| 36416 |
|
187 |
178 |
$0.00 |
| H0033 |
Oral medication administration, direct observation |
122 |
120 |
$0.00 |
| 3008F |
|
572 |
500 |
$0.00 |
| 99000 |
|
33 |
32 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
32 |
32 |
$0.00 |
| 99072 |
|
1,545 |
1,483 |
$0.00 |
| S5000 |
Prescription drug, generic |
80 |
79 |
$0.00 |